Belgium · Series A startup

Who invested in Camel-IDS

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$42Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $42MNov 2018
Led by
Gimv and V-Bio Ventures
Investors
6 (2 led)
See who backed them

The rounds

  1. Nov 2018
    Series A$42M

    Reported by Healthcap

Everyone who backed them

GimvPrivate equity1round, led 1
V-Bio VenturesVC firm1round, led 1
HealthCapVC firm1round
BioMedPartnersPrivate equity1round
Novo SeedsVC firm1round
Pontifaxno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Camel-IDS

Who invested in Camel-IDS?

Camel-IDS's investors include Gimv, V-Bio Ventures, HealthCap, BioMedPartners and Novo Seeds, and 1 more on record. Gimv led its latest round.

How much has Camel-IDS raised?

Camel-IDS has raised $42M across 1 round since 2018.

When did Camel-IDS last raise?

Camel-IDS's most recent round was a Series A of $42M in Nov 2018, led by Gimv.

What was Camel-IDS's biggest round?

Its most recent round, $42M in Nov 2018, is also its largest on record.

Who backed Camel-IDS first?

Camel-IDS's first round on record, in Nov 2018, was backed by Gimv, V-Bio Ventures and HealthCap and 3 others.

What stage is Camel-IDS at?

Camel-IDS's latest named round is a Series A, in Nov 2018.

Where is Camel-IDS based?

Camel-IDS is based in Belgium.

Who led Camel-IDS's rounds?

Gimv led the Series A in 2018.

Companies like Camel-IDS

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.